The discriminative ability of CEA in healthy + benign vs. early-stage CRC samples was (p = 0.04572), whereas for healthy + benign vs. early and late-stage CRC samples it was also significant (p = 0.05052), as shown in Figure 2. Here, CEACAM5 is linked to colorectal carcinoma.